Tarsus Pharmaceuticals, Inc. TARS Inventory, Current And Noncurrent, Net
Inventory, Current And Noncurrent, Net at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept tars:InventoryCurrentAndNoncurrentNet.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s inventory, current and noncurrent, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s inventory, current and noncurrent, net?
- Tarsus Pharmaceuticals, Inc. (TARS) reported inventory, current and noncurrent, net of $7.1M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s inventory, current and noncurrent, net changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s inventory, current and noncurrent, net increased by 35.6% year-over-year, from $5.24M to $7.1M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s inventory, current and noncurrent, net?
- Over 2 years (2023 to 2025), Tarsus Pharmaceuticals, Inc.'s inventory, current and noncurrent, net has grown at a 49.1% compound annual growth rate (CAGR), from $3.11M to $6.9M.
- What does inventory, current and noncurrent, net mean?
- The total net value of all inventory assets, including raw materials, work-in-progress, and finished goods, across both current and non-current classifications. This metric provides a comprehensive view of the company's total investment in physical goods and supply chain assets.